NephroGenex, Inc. Deferred Tax Assets, Valuation Allowance

NephroGenex, Inc. Deferred Tax Assets, Valuation Allowance

NephroGenex, Inc. had Deferred Tax Assets, Valuation Allowance of $27.73 million as of 2015-12-31, per its 10-K filed 2016-03-29.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance

us-gaap:DeferredTaxAssetsValuationAllowance · last filed 2016-03-29

• 2015-12-31: Deferred Tax Assets, Valuation Allowance $27.73M.
• 2014-12-31: Deferred Tax Assets, Valuation Allowance $19.33M.
• 2013-12-31: Deferred Tax Assets, Valuation Allowance $14.12M.